These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 11092996

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lipid profile changes during the first year after kidney transplantation: risk factors and influence of the immunosuppressive drug regimen.
    Spinelli GA, Felipe CR, Park SI, Mandia-Sampaio EL, Tedesco-Silva H, Medina-Pestana JO.
    Transplant Proc; 2011 Dec; 43(10):3730-7. PubMed ID: 22172836
    [Abstract] [Full Text] [Related]

  • 5. Effects of cyclosporine-tacrolimus switching in posttransplantation hyperlipidemia on high-density lipoprotein 2/3, lipoprotein a1/b, and other lipid parameters.
    Seymen P, Yildiz M, Türkmen MF, Titiz MI, Seymen HO.
    Transplant Proc; 2009 Dec; 41(10):4181-3. PubMed ID: 20005364
    [Abstract] [Full Text] [Related]

  • 6. Lipid profile during azathioprine or mycophenolate mofetil combinations with cyclosporine and steroids.
    Akman B, Uyar M, Afsar B, Sezer S, Ozdemir FN, Haberal M.
    Transplant Proc; 2007 Dec; 39(1):135-7. PubMed ID: 17275490
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prospective study of lipid disorders in FK506-versus cyclosporine-treated renal transplant patients.
    Vela CG, Cristol JP, Descomps B, Mourad G.
    Transplant Proc; 2000 Mar; 32(2):398. PubMed ID: 10715453
    [No Abstract] [Full Text] [Related]

  • 9. Everolimus versus azathioprine in a cyclosporine and ketoconazole-based immunosuppressive therapy in kidney transplant: 3-year follow-up of an open-label, prospective, cohort, comparative clinical trial.
    Gonzalez F, Espinoza M, Herrera P, Rocca X, Reynolds E, Lorca E, Roessler E, Hidalgo J, Espinoza O.
    Transplant Proc; 2010 Mar; 42(1):270-2. PubMed ID: 20172327
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone.
    Wilkinson AH, Smith JL, Hunsicker LG, Tobacman J, Kapelanski DP, Johnson M, Wright FH, Behrendt DM, Corry RJ.
    Transplantation; 1989 Feb; 47(2):293-6. PubMed ID: 2645716
    [Abstract] [Full Text] [Related]

  • 12. Comparing an early corticosteroid/late calcineurin-free immunosuppression protocol to a sirolimus-, cyclosporine A-, and prednisone-based regimen for pancreas-kidney transplantation.
    Knight RJ, Podder H, Kerman RH, Lawless A, Katz SM, Van Buren CT, Gaber AO, Kahan BD.
    Transplantation; 2010 Mar 27; 89(6):727-32. PubMed ID: 20195219
    [Abstract] [Full Text] [Related]

  • 13. The effects of steroid withdrawal on the lipoprotein profiles of cyclosporine-treated kidney and kidney-pancreas transplant recipients.
    Hricik DE, Bartucci MR, Mayes JT, Schulak JA.
    Transplantation; 1992 Nov 27; 54(5):868-71. PubMed ID: 1440855
    [Abstract] [Full Text] [Related]

  • 14. [Lipid disturbances in children after kidney transplantation].
    Latoszyńska J, Boguszewska-Baczkowska A, Grenda R.
    Pediatr Pol; 1995 Feb 27; 70(2):139-43. PubMed ID: 7603797
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A.
    Park JW, Siekmeier R, Lattke P, Merz M, Mix C, Schüler S, Jaross W.
    J Cardiovasc Pharmacol Ther; 2001 Oct 27; 6(4):351-61. PubMed ID: 11907637
    [Abstract] [Full Text] [Related]

  • 16. [Withdrawal of prednisone from a triple combination of immunosuppressive agents after kidney transplantation].
    Matl I, Lácha J, Lodererová A, Símová M, Teplan V, Lánská V, Vítko S.
    Cas Lek Cesk; 2000 Mar 01; 139(4):115-9. PubMed ID: 10838741
    [Abstract] [Full Text] [Related]

  • 17. Early steroid withdrawal after kidney transplantation.
    Yagisawa T, Toma H, Ota K, Tanabe K, Ishikawa N, Tokumoto N, Yaguchi H, Nakada T.
    Transplant Proc; 1996 Jun 01; 28(3):1342-5. PubMed ID: 8658686
    [No Abstract] [Full Text] [Related]

  • 18. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI, Flechner SM, Van Buren CT, Kerman RH, Kahan BD.
    Transplant Proc; 1985 Aug 01; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract] [Full Text] [Related]

  • 19. Hyperlipidemia in long-term survivors of pediatric renal transplantation.
    Sharma AK, Myers TA, Hunninghake DB, Matas AJ, Kashtan CE.
    Clin Transplant; 1994 Jun 01; 8(3 Pt 1):252-7. PubMed ID: 8061364
    [Abstract] [Full Text] [Related]

  • 20. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
    Aichberger C, Eberl T, Riedmann B, Pernthaler H, Ofner D, Königsrainer A, Margreiter R.
    Clin Transplant; 1996 Apr 01; 10(2):209-12. PubMed ID: 8664521
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.